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Table 1
Antibiotic failure in MRSA infections
Antibiotic number of
patents
receiving
the
antibiotic
number of
patients
who failed
the
antibiotic
percentage
of failure
(%)
vancomycin 164 15 9.1
daptomycin 21 3 1.42
tigecycline 13 4 30.7
telavancin 1 0 0
trimethoprim-sulfamethoxazole 15 11 73.3
linezolid 11 2 18.1
doxycycline 2 1 50
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Background: Uncontrolled usage of antibiotics has caused the
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Background: Despite the availability of multiple new antibi-
tics for the treatment of methicillin resistant staphylococcus
ureus (MRSA), vancomycin has remained an important anti-
taphylococcal antibiotic. Even after 50 years since it was ﬁrst
ntroduced, it still remains the drug of choice for treatment of com-
licated MRSA infections during hospitalization. If vancomycin is
ptimally dosed, clinical failure rates with vancomycin are fairly
ow. In this study, we analyzed the pattern of antibiotic usage for
reatment of MRSA infections and their outcomes in a tertiary care
ospital at Springﬁeld, Illinois.
Methods: This study is a retrospective review of 304 charts
f patients with MRSA infections seen between January 2009 and
ecember 2009.We analyzed the type of infection, choice of antibi-
tic and their outcome in these patients. Tables 1 and 2 summarize
he results. For the purpose of this study,we deﬁned treatment fail-
re as clinically worsening while on treatment requiring change to
nother anti-staphylococcal antibiotic for the same infection, iso-
able 2
ype of infection and speciﬁc antibiotic failure
Skin and
soft tissue
infection
bone and
joint
infection
vancomycin 13 17
trimethoprim-sulfamethoxazole 3 41
daptomycin - 1
clindamycin 3 1
levoﬂoxacin 6 1
linezolid 1 -
tigecycline - 4
doxycycline - 1
telavancin - -
total 26 29Figure 1. Antibiotic (all) failure in the type of infection.
lation of MRSA from the same or another site while on presumed
effective treatment.
Results: Of the 304 charts screened, 49 charts had incomplete
information. Of the remaining 255 patients included in the study,
the following tables andﬁgures summarize the antibiotic usage and
failure.
Figure 1.
Conclusion: Vancomycin was used in the majority of serious
MRSA infections and the antibiotic failure with vancomycin was
lower thanmost other antibiotics used except for daptomycin. This
study is unique since it assesses the usage of different anti staphy-
lococcal drugs and their failure rates. The data is afﬁrmative for
vancomycin as the drug of choice for complicated MRSA infections
despite reported increase in failure rates.
http://dx.doi.org/10.1016/j.ijid.2012.05.629
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Bacteriophages–alternativeapproach to treat infections caused
by bacterial pathogens
M. Kutateladze ∗, R. Adamia
Eliava Institute of bacteriophages, Tbilisi, Georgiarapid development of multidrug resistant bacterial pathogens all
over the world. The challenges in the treatment of infectious
diseases are leading the search for alternative remedies. In the
blood
stream
infection
device/catheter Urinary
tract
infections
respiratory
infection
17 1 1 2
4 - - -
2 - - -
3 - - -
4 1 1 2
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